New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

XHEvsBBPETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.42%
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-1.71%

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. XHE's top 2 sector exposures are Healthcare and Finance. In contrast, BBP's top sector exposures are Healthcare. XHE is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.34% for BBP. XHE is up 3.73% year-to-date (YTD) with +$13M in YTD flows. BBP performs better with 32.02% YTD performance, and +$50M in YTD flows. Run a side-by-side ETF comparison of XHE and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs BBP performance and flow charts

Performance

-4.0-2.00.02.04.06.08.0%Aug 10Aug 17Aug 24Aug 31Sep 7

Cumulative Flows

0 M2 M4 M6 M8 M10 MAug 10Aug 17Aug 24Aug 31Sep 7

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/09/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
BBP
-3.04%+4.09%
+10.11%+23.23%
+3.73%+32.02%
+10.83%+49.71%
+9.19%+98.63%
-30.39%+100.65%
Flows
XHE
BBP
+$5M+$5M
+$14M+$20M
+$13M+$50M
+$2M+$62M
-$264M+$68M
-$380M+$61M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
BBP
+24.07%+25.85%
+22.81%+25.14%
+22.21%+24.72%
+24.83%+26.61%
Max drawdown
XHE
BBP
-5.67%-9.34%
-18.20%-9.59%
-24.35%-25.54%
-49.37%-37.61%
Max drawdown duration
XHE
BBP
21d39d
207d48d
565d292d
1771d586d
Trading data

Create an account to view trading data

Join for free
XHE
BBP
Last sale
9/10/2026 at 1:30 PM
$89.53
$103.47
Previous close
09/09/2026
$91.41
$105.52
Consolidated volume
09/09/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
XHE
BBP
Last price
$89.53
$103.47
1D performance
-2.06%
-1.94%
AuM$173.68 M$115.83 M
E/R0.35%0.34%
Characteristics
XHE
BBP
Management strategyPassivePassive
ProviderState Street Investment ManagementVIRTUS Investment Partners
BenchmarkS&P Health Care Equipment Select Industry IndexLifeSci Biotechnology Products Index
N° of holdings6666
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
93.56%
Other
6.44%
BBP
USA
86.5%
Other
13.5%

Sectors

XHE
Healthcare
98.72%
Other
1.28%
BBP
Healthcare
98.2%
Other
1.8%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

30.19%
BBP

Total weight of top 15 holdings out of 15

26.78%

Top 15 holdings

Data as of July 31, 2026
XHE
AtriCure, Inc.
2.14%
Glaukos Corp.
2.13%
Dentsply Sirona, Inc.
2.08%
Enovis Corp.
2.07%
Integer Holdings Corp.
2.07%
Butterfly Network, Inc.
2.06%
Neogen Corp.
2.05%
Artivion, Inc.
2.05%
Baxter International, Inc.
2.01%
CONMED Corp.
1.99%
Merit Medical Systems, Inc.
1.98%
QuidelOrtho Corp.
1.94%
ICU Medical, Inc.
1.88%
Tandem Diabetes Care, Inc.
1.88%
Inspire Medical Systems, Inc.
1.85%
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
Frequently asked questions about XHE and BBP

How have the XHE and BBP ETFs performed in 2026?

As of September 9, 2026, XHE is up 3.73% year-to-date (YTD), while BBP has returned 32.02%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or BBP?

Year-to-date, the XHE ETF saw +$13M in flows, compared to +$50M for BBP.

Which ETF is more volatile: XHE or BBP?

Over the past year, XHE had a volatility of 22.81%, while BBP experienced 25.14%.

Which ETF is bigger: XHE or BBP?

As of September 9, 2026, XHE holds $173.68 M in assets under management (AUM), while BBP manages $115.83 M.

What sectors do the XHE and BBP ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.

What are the top holdings of the XHE ETF and BBP ETF?

XHE top holdings include AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc.. BBP holds in its top three: Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc..

Which ETF is more diversified: XHE or BBP?

XHE holds 66 securities with 30.19% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 26.78%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder